| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Divisions of Nephrology*
and Clinical
Pharmacology,
Medizinische Hochschule,
Hannover, Germany, and NeXstar
Pharmaceuticals,
Boulder, Colorado
Mesangial cell proliferation and matrix accumulation, driven by platelet-derived growth factor (PDGF), contribute to many progressive renal diseases. In a novel approach to antagonize PDGF, we investigated the effects of a nuclease-resistant high-affinity oligonucleotide aptamer in vitro and in vivo. In cultured mesangial cells, the aptamer markedly suppressed PDGF-BB but not epidermal- or fibroblast-growth-factor-2-induced proliferation. In vivo effects of the aptamer were evaluated in a rat mesangioproliferative glomerulonephritis model. Twice-daily intravenous (i.v.) injections from days 3 to 8 after disease induction of 2.2 mg/kg PDGF-B aptamer, coupled to 40-kd polyethylene glycol (PEG), led to 1) a reduction of glomerular mitoses by 64% on day 6 and by 78% on day 9, 2) a reduction of proliferating mesangial cells by 95% on day 9, 3) markedly reduced glomerular expression of endogenous PDGF B-chain, 4) reduced glomerular monocyte/macrophage influx on day 6 after disease induction, and 5) a marked reduction of glomerular extracellular matrix overproduction (as assessed by analysis of fibronectin and type IV collagen) both on the protein and mRNA level. The administration of equivalent amounts of a PEG-coupled aptamer with a scrambled sequence or PEG alone had no beneficial effect on the natural course of the disease. These data show that specific inhibition of growth factors using custom-designed, high-affinity aptamers is feasible and effective.
This article has been cited by other articles:
![]() |
J. Andrae, R. Gallini, and C. Betsholtz Role of platelet-derived growth factors in physiology and medicine Genes & Dev., May 15, 2008; 22(10): 1276 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Floege, F. Eitner, and C. E. Alpers A New Look at Platelet-Derived Growth Factor in Renal Disease J. Am. Soc. Nephrol., January 1, 2008; 19(1): 12 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rampino, G. Soccio, M. Gregorini, C. Guidetti, M. Marasa, M. Maggio, V. Panichi, M. Migliori, C. Libetta, and A. Dal Canton Neutralization of Macrophage-Stimulating Protein Ameliorates Renal Injury in Anti-Thy 1 Glomerulonephritis J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1486 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ostendorf, S. Rong, P. Boor, S. Wiedemann, U. Kunter, U. Haubold, C. R.C. van Roeyen, F. Eitner, H. Kawachi, G. Starling, et al. Antagonism of PDGF-D by Human Antibody CR002 Prevents Renal Scarring in Experimental Glomerulonephritis J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1054 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R.C. van Roeyen, F. Eitner, S. Martinkus, S. R. Thieltges, T. Ostendorf, D. Bokemeyer, B. Luscher, J. M. Luscher-Firzlaff, J. Floege, and P. R. Mertens Y-Box Protein 1 Mediates PDGF-B Effects in Mesangioproliferative Glomerular Disease J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2985 - 2996. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Helmling, C. Maasch, D. Eulberg, K. Buchner, W. Schroder, C. Lange, S. Vonhoff, B. Wlotzka, M. H. Tschop, S. Rosewicz, et al. Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer PNAS, September 7, 2004; 101(36): 13174 - 13179. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ostendorf, C. van Roeyen, R. Westenfeld, A. Gawlik, M. Kitahara, E. de Heer, D. Kerjaschki, J. Floege, and M. Ketteler Inducible Nitric Oxide Synthase-Derived Nitric Oxide Promotes Glomerular Angiogenesis via Upregulation of Vascular Endothelial Growth Factor Receptors J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2307 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mitchell, K. Rodgers, J. Hanly, B. McMahon, H. R. Brady, F. Martin, and C. Godson Lipoxins Inhibit Akt/PKB Activation and Cell Cycle Progression in Human Mesangial Cells Am. J. Pathol., March 1, 2004; 164(3): 937 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Hudkins, D. G. Gilbertson, M. Carling, S. Taneda, S. D. Hughes, M. S. Holdren, T. E. Palmer, S. Topouzis, A. C. Haran, A. L. Feldhaus, et al. Exogenous PDGF-D Is a Potent Mesangial Cell Mitogen and Causes a Severe Mesangial Proliferative Glomerulopathy J. Am. Soc. Nephrol., February 1, 2004; 15(2): 286 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Lin, R.-H. Chen, Y.-M. Chen, W.-C. Chiang, T.-J. Tsai, and B.-S. Hsieh Pentoxifylline Inhibits Platelet-Derived Growth Factor-Stimulated Cyclin D1 Expression in Mesangial Cells by Blocking Akt Membrane Translocation Mol. Pharmacol., October 1, 2003; 64(4): 811 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Floege, F. Eitner, C. van Roeyen, and T. Ostendorf PDGF-D and Renal Disease: Yet Another One of Those Growth Factors? J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2690 - 2691. [Full Text] [PDF] |
||||
![]() |
T. Ostendorf, C. R.C. van Roeyen, J. D. Peterson, U. Kunter, F. Eitner, A. J. Hamad, G. Chan, X.-C. Jia, J. Macaluso, G. Gazit-Bornstein, et al. A Fully Human Monoclonal Antibody (CR002) Identifies PDGF-D as a Novel Mediator of Mesangioproliferative Glomerulonephritis J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2237 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kriz, B. Hahnel, H. Hosser, T. Ostendorf, S. Gaertner, B. Kranzlin, N. Gretz, F. Shimizu, and J. Floege Pathways to Recovery and Loss of Nephrons in Anti-Thy-1 Nephritis J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1904 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Tavitian In vivo imaging with oligonucleotides for diagnosis and drug development Gut, June 1, 2003; 52(90004): iv40 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Balasubramaniam, T. D. Le Cras, D. D. Ivy, T. R. Grover, J. P. Kinsella, and S. H. Abman Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L826 - L833. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pietras, K. Rubin, T. Sjoblom, E. Buchdunger, M. Sjoquist, C.-H. Heldin, and A. Ostman Inhibition of PDGF Receptor Signaling in Tumor Stroma Enhances Antitumor Effect of Chemotherapy Cancer Res., October 1, 2002; 62(19): 5476 - 5484. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lupold, B. J. Hicke, Y. Lin, and D. S. Coffey Identification and Characterization of Nuclease-stabilized RNA Molecules That Bind Human Prostate Cancer Cells via the Prostate-specific Membrane Antigen Cancer Res., July 15, 2002; 62(14): 4029 - 4033. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bokemeyer, D. Panek, H. J. Kramer, M. Lindemann, M. Kitahara, P. Boor, D. Kerjaschki, J. M. Trzaskos, J. Floege, and T. Ostendorf In Vivo Identification of the Mitogen-Activated Protein Kinase Cascade as a Central Pathogenic Pathway in Experimental Mesangioproliferative Glomerulonephritis J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1473 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ulrich, M. H. Magdesian, M. J. M. Alves, and W. Colli In Vitro Selection of RNA Aptamers That Bind to Cell Adhesion Receptors of Trypanosoma cruzi and Inhibit Cell Invasion J. Biol. Chem., May 31, 2002; 277(23): 20756 - 20762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kitahara, F. Eitner, T. Ostendorf, U. Kunter, U. Janssen, R. Westenfeld, K. Matsui, D. Kerjaschki, and J. Floege Selective Cyclooxygenase-2 Inhibition Impairs Glomerular Capillary Healing in Experimental Glomerulonephritis J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1261 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Eitner, T. Ostendorf, C. Van Roeyen, M. Kitahara, X. Li, K. Aase, H.-J. Grone, U. Eriksson, and J. Floege Expression of a Novel PDGF Isoform, PDGF-C, in Normal and Diseased Rat Kidney J. Am. Soc. Nephrol., April 1, 2002; 13(4): 910 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ostendorf, U. Kunter, C. van Roeyen, S. Dooley, N. Janjic, J. Ruckman, F. Eitner, and J. Floege The Effects of Platelet-Derived Growth Factor Antagonism in Experimental Glomerulonephritis Are Independent of the Transforming Growth Factor-{beta} System J. Am. Soc. Nephrol., March 1, 2002; 13(3): 658 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yanagita, H. Arai, T. Nakano, K. Ohashi, K. Mizuno, A. Fukatsu, T. Doi, and T. Kita Gas6 Induces Mesangial Cell Proliferation via Latent Transcription Factor STAT3 J. Biol. Chem., November 2, 2001; 276(45): 42364 - 42369. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. OSTENDORF, U. KUNTER, H. J. GRÖNE, F. BAHLMANN, H. KAWACHI, F. SHIMIZU, K. M. KOCH, N. JANJIC, and J. FLOEGE Specific Antagonism of PDGF Prevents Renal Scarring in Experimental Glomerulonephritis J. Am. Soc. Nephrol., May 1, 2001; 12(5): 909 - 918. [Abstract] [Full Text] |
||||
![]() |
K. Pietras, A. Östman, M. Sjöquist, E. Buchdunger, R. K. Reed, C.-H. Heldin, and K. Rubin Inhibition of Platelet-derived Growth Factor Receptors Reduces Interstitial Hypertension and Increases Transcapillary Transport in Tumors Cancer Res., April 1, 2001; 61(7): 2929 - 2934. [Abstract] [Full Text] |
||||
![]() |
M. Yanagita, H. Arai, K. Ishii, T. Nakano, K. Ohashi, K. Mizuno, B. Varnum, A. Fukatsu, T. Doi, and T. Kita Gas6 Regulates Mesangial Cell Proliferation through Axl in Experimental Glomerulonephritis Am. J. Pathol., April 1, 2001; 158(4): 1423 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. FLOEGE and J. FEEHALLY IgA Nephropathy: Recent Developments J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2395 - 2403. [Full Text] |
||||
![]() |
O. Leppanen, N. Janjic, M.-A. Carlsson, K. Pietras, M. Levin, C. Vargeese, L. S. Green, D. Bergqvist, A. Ostman, and C.-H. Heldin Intimal Hyperplasia Recurs After Removal of PDGF-AB and -BB Inhibition in the Rat Carotid Artery Injury Model Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20 (11): e89 - e95. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rhodes, A. Deakin, J. Spaull, B. Coomber, A. Aitken, P. Life, and S. Rees The Generation and Characterization of Antagonist RNA Aptamers to Human Oncostatin M J. Biol. Chem., September 8, 2000; 275(37): 28555 - 28561. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |